/CSUI

CSUI Stock - Cannabis Suisse Corp.

Q: What is the analyst price target for CSUI?

Analyst price target information is not currently available for CSUI.

Q: What is CSUI's market cap?

Market capitalization information is not currently available for CSUI.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.01+235.71%

+$0.01 (+235.71%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CSUI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-4.65

52W High$0.03

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$22,500	$30,000	$10,000	$7,770	$50,850
Gross Profit	$432	$-67	$834	$6,036	$-51,798
Gross Margin	1.9%	-0.2%	8.3%	77.7%	-101.9%
Operating Income	$-283,769	$-257,000	$-342,682	$-157,155	$-358,000
Net Income	$-456,142	$-1,265,000	$-351,547	$-187,890	$-411,000
Net Margin	-2027.3%	-4216.7%	-3515.5%	-2418.1%	-808.3%
EPS	$-0.01	$-0.03	$-0.01	$-0.01	$-0.01

Company Overview

Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. It provides health-related supplements, and face masks and disinfectants, as well as retails cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California.

Visit Website

Earnings History & Surprises

CSUI

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q4 2023

EPS Surprise History

Q1 23

No data

Q3 23

No data

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Nov 30, 2023	—	$-0.00	—	—
Q3 2023	Aug 31, 2023	—	$-0.00	—	—
Q1 2023	Feb 28, 2023	—	$-0.00	—	—

Frequently Asked Questions about CSUI

What is CSUI's current stock price?

Cannabis Suisse Corp. (CSUI) is currently trading at $0.01 per share. The stock has moved +235.71% today.

What is the analyst price target for CSUI?

No analyst price targets are currently available for this stock.

What sector is Cannabis Suisse Corp. in?

Cannabis Suisse Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CSUI's market cap?

Cannabis Suisse Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CSUI pay dividends?

No, Cannabis Suisse Corp. does not currently pay a dividend to shareholders.